Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Long-term outcomes of intensive immunosuppressive therapy combined with eltrombopag in patients with severe aplastic anemia

View Full Paper
Ask AI
Bookmark
Share

Authors

CQChao QinYZYawen ZhangLFLei Fan

Discussion

Loading...

Member takes

Overview

Observational study reveals eltrombopag improves complete response in SAA, highlighting clonal evolution and myeloid neoplasm risks.

Key Points

  • To explore the long-term efficacy of eltrombopag combined with IST in severe aplastic anemia patients.
  • Follow-up on 69 adult SAA patients from May 2014 to October 2021
  • 34 patients received eltrombopag combined with IST
  • Cytogenetic testing was conducted, analyzing mutations related to myeloid tumors
  • Five-year follow-up to assess hemopoietic recovery and relapse rates.
  • 89.9% of patients became transfusion independent after IST
  • Complete response rates were significantly higher with eltrombopag compared to IST alone
  • Age positively correlated with relapse risk, with a 5-year cumulative relapse rate of 6.0%
  • Mutation rates for key genes significantly increased after IST treatment.

Cite This Study

Qin et al. (2025) studied this question.

synapsesocial.com/papers/693624dd4fa91c937236d182https://doi.org/10.1182/blood-2025-6431
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Outcomes of eltrombopag combined with immunosuppressive therapy in adults with severe aplastic anemia: A large, propensity-matched retrospective analysis2025
  2. 2A Multicenter, Retrospective Study Comparing Immunosuppressive Therapy Combined with Eltrombopag to Immunosuppressive Therapy Alone as Front-Line Treatment for Pediatric Severe Aplastic Anemia.2025 · 2 citations
  3. 3Initiating Eltrombopag (EPAG) Early for aplastic Anemia (AA) may Lead to greater clinical benefits: A systematic review and meta-analysis2025
  4. 4Thrombopoietin receptor agonists combined with intensive immunosuppressive therapy improve outcomes in elderly patients with severe aplastic anemia: A single-center retrospective study2025
  5. 5This Meta-Analysis Evaluates the Optimal Timing for Initiating and Discontinuing Eltrombopag for Aplastic Anemia2025